AIIC
CARM

AJU IB Investment Company’s Carisma Therapeutics CARM Stock Holding History

AJU IB Investment Company’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-718,332
Closed -$281K – 8
2025
Q2 		$281K Hold
718,332
– – 0.31% 5
2025
Q1 		$223K Hold
718,332
– – 0.27% 6
2024
Q4 		$301K Buy
+718,332
New +$592K 0.29% 7

Other funds holding CARM

MC
Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return

AJU IB Investment Company's CARM Position: Q3 2025 in Review

AJU IB Investment Company sold out of Carisma Therapeutics (CARM) in Q3 2025, closing a stake of 718,332 shares — an estimated $281K sold.

AJU IB Investment Company first reported a position in CARM in Q4 2024 and held it in 3 quarters. The position peaked at $301K in Q4 2024. 33 funds tracked by Wall St. Rank hold CARM as of Q3 2025.

  • AJU IB Investment Company reported no remaining Carisma Therapeutics position as of Q3 2025 after selling out during the quarter.
  • AJU IB Investment Company sold 718,332 Carisma Therapeutics shares in Q3 2025, an estimated $281K.
  • AJU IB Investment Company first reported a position in Carisma Therapeutics in Q4 2024 and held it in 3 quarters.
  • AJU IB Investment Company's Carisma Therapeutics position peaked at $301K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q3 2025.

Based on AJU IB Investment Company's 13F filing for Q3 2025, filed 6 Nov 2025.